Innoviva Stock Just This: Why a Fund Bought $2.5M More
A boutique fund recently boosted its Innoviva stake by $2.5 million, raising questions about the stock's modest 10% g...
Timing bond allocations can reduce risk and stabilize income in retirement. Learn indicators and phased approaches to use bonds effectively.
22,161 articlesA boutique fund recently boosted its Innoviva stake by $2.5 million, raising questions about the stock's modest 10% g...
A quartet of high-yield international ETFs has posted stronger returns than the S&P 500 over the past year, deliverin...
A major fund disclosed a new stake in Everus Construction Group, worth about $185 million, fueling discussion about t...
Markets open with caution as AI jitters mix with Middle East tensions. This article breaks down what this means for y...
Bitcoin often sparks fierce arguments: is it dead or just resting? This article breaks down three substantial concern...
Big events bring big costs beyond ticketing and catering. Explore what a six-figure NYC permit can teach about budget...
A simple, time-tested approach often beats chasing hot sectors. Learn why a broad-market ETF could be your winning mo...
A veteran financial writer dives into a framework that aims to outpace the S&P over generations. Learn how Davis Fund...
Starting with $1,000, you can anchor a tech-forward portfolio on three core players. This guide explains why these co...
Vanguard Real Estate ETF faces a crucial test as the 10-year yield that drives REIT valuations hovers near 4.6%, pote...
Markets shift from mega-cap tech to overlooked small firms. This story highlights three small-cap ETFs to buy before ...
The S&P 500 has slipped to a just 3-month low even as oil prices climb. This article breaks down what this divergence...